Hilary Shaw

Statistics

Publications

Citations

269

H-Index

Active since

2013

Affiliations

Ludwig-Maximilians-Universität München(Current)

Hilary Shaw is an author at Ludwig-Maximilians-Universität München specializing in placebo-controlled efficacy assessment, vaccine immunology, and controlled field trials.

Publications per year

2013–2019

Publications

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

R.H. Behrens, Jakob P. Cramer, Tomáš Jelı́nek et al. · The Lancet Infectious Diseases · 2013 · 100 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

1–2 of 2